Drug Trial Radar · NCT02612129
Arimoclomol Prospective Study in Participants Diagnosed With Niemann-Pick Disease Type C
Last checked: Nov 19, 2026Latest source record: Nov 29, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
50
Actual
Start
Jun 14, 2016
Primary completion
Jun 25, 2018
Study completion Oct 31, 2024
Sponsor
- Lead sponsor
- ZevraDenmarkIndustry
- Sponsor type
- Industry
- First posted
- Nov 23, 2015
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 2 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A prospective, randomized, double-blind, placebo controlled therapeutic study in participants with confirmed diagnosis of Niemann-Pick disease type C (NPC). The purpose of this study is to assess the efficacy and safety of arimoclomol (compared to placebo) when it is administered as an add-on therapy to the participant's current prescribed best routine clinical care; participant's routine clinical care may, or may not, include miglustat. The CT-ORZY-NPC-002 study has been expanded to include an open label paediatric sub-study including participants aged 6 to \<24 months at study enrolment.
Conditions
- Niemann-Pick Disease, Type C
Interventions
arimoclomolDrug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the Niemann-Pick Disease Type C (NPC) Disease Severity Assessed Based on the 5-domain NPCCSS Total ScoresTime frame: Baseline to Month 12
Locations
14 sites in 9 countries. Site status is shown where the registry gives one.
UCSF Benioff Children's Hospital Oakland
Oakland, California
Mayo Clinic Children's Center
Rochester, Minnesota
University Hospital Copenhagen (Rigshospitalet)
Copenhagen, Denmark
CHU de Montpellier
Montpellier, France
Hôpital Trousseau
Paris, France
Villa Metabolica, Universitätsmedizin Mainz
Mainz, Germany
Dr. von Haunersches Kinderspital der Universität München
Munich, Germany
Ospedale Pediatrico Bambino Gesù
Rome, Italy
Azienda Ospedaliero-Universitaria "Santa Maria della Misericordia" di Udin
Udine, Italy
The Children´s Memorial Istitute Warsaw
Warsaw, Poland
Hospital Vall D'Hebron
Barcelona, Spain
INSELSPITAL University Hospital Bern
Bern, Switzerland
Birmingham Children's Hospital
Birmingham, United Kingdom
Great Ormond Street Hospital
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.